Format

Send to

Choose Destination
Hematol Oncol Clin North Am. 2013 Oct;27(5):1049-61. doi: 10.1016/j.hoc.2013.07.009.

Targeted therapies in rare sarcomas: IMT, ASPS, SFT, PEComa, and CCS.

Author information

1
Adult Sarcoma Medical Oncology Unit, Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, via Venezian 1, Milan 20133, Italy. Electronic address: silvia.stacchiotti@istitutotumori.mi.it.

Abstract

This article highlights the data currently available on the activity of targeted medical treatment in a subgroup of rare entities within soft tissue sarcomas, including inflammatory myofibroblastic tumor, alveolar soft part sarcoma, solitary fibrous tumor, malignant perivascular epithelioid cell tumor (PEComa), and clear cell sarcoma.

KEYWORDS:

Alveolar soft part sarcoma; Chemotherapy; Clear cell sarcoma; Hemangiopericytoma; Inflammatory myofibroblastic tumor; Perivascular epithelioid cell tumor; Sarcoma; Solitary fibrous tumor

PMID:
24093175
DOI:
10.1016/j.hoc.2013.07.009
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center